Cite
MLA Citation
Hong Zhu et al.. “The excellent antitumor effect of apatinib alone as second-line therapy in a patient with sorafenib-refractory hepatocellular carcinoma.” Medicine, vol. 97, no. 25, 2018, p. . http://access.bl.uk/ark:/81055/vdc_100066545531.0x000038